Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find out the safety and effectiveness of Glycolic Acid Chemical Peels compared to Salicylic Acid Chemical Peels for the treatment of melasma.


Clinical Trial Description

Participants in this study will be patients who are clinically diagnosed with at least a 2 x 2 cm patch of melasma on each side of their face (forehead or cheek). One half of the subject's face will be randomly selected to receive 4 treatments of 30% glycolic acid peels and the other half of the face will receive 4 treatments of 30% salicylic acid peels/ weeks 0, 4, 8, and 12. Follow up visit will be at week 16. This study is a pilot study designed to determine feasibility of these procedures. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01976286
Study type Interventional
Source Northwestern University
Contact
Status Active, not recruiting
Phase N/A
Start date January 2015
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT01976273 - A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma N/A
Completed NCT05119413 - Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma Phase 2
Terminated NCT00863278 - Treatment of Melasma With Stabilized Kligman Preparation Associated or Not With Pulsed Dye Laser Phase 4
Recruiting NCT00927771 - Azelaic Acid Versus Hydroquinone in Melasma Phase 4
Not yet recruiting NCT05930392 - Comparative Evaluation of Microsurgery vs Conventional Surgical Technique of Gingival Depigmentation N/A
Not yet recruiting NCT05930366 - Comparative Evaluation of Microsurgery vs Diode Laser Technique of Gingival Depigmentation N/A
Not yet recruiting NCT03585179 - Oral and Topical Tranexamic Acid for the Treatment of Melasma Phase 3